Frank S. Menniti

Person

Mystic, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
- Patent number 12,161,624
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 12,162,890
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...
- Patent number 12,145,909
- Issue date Nov 19, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NMDA receptor modulators and uses thereof
- Patent number 11,807,650
- Issue date Nov 7, 2023
- Novartis AG
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 11,648,253
- Issue date May 16, 2023
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 11,541,057
- Issue date Jan 3, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NMDA receptor modulators and uses thereof
- Patent number 11,274,107
- Issue date Mar 15, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 11,236,104
- Issue date Feb 1, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
- Patent number 11,116,749
- Issue date Sep 14, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 10,973,825
- Issue date Apr 13, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...
- Patent number 10,781,174
- Issue date Sep 22, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 10,626,122
- Issue date Apr 21, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 10,500,205
- Issue date Dec 10, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allos...
- Patent number 10,239,835
- Issue date Mar 26, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
- Patent number 10,052,306
- Issue date Aug 21, 2018
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
- Patent number 9,540,324
- Issue date Jan 10, 2017
- LUC THERAPEUTICS, INC.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazole derivatives
- Patent number 7,078,529
- Issue date Jul 18, 2006
- Pfizer Inc.
- Mark A. Sanner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NMDA NR2B antagonists for treatment
- Patent number 7,019,016
- Issue date Mar 28, 2006
- Pfizer Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NMDA NR2B antagonists for treatment
- Patent number 6,958,351
- Issue date Oct 25, 2005
- Pfizer Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical combinations for the treatment of stroke and traumat...
- Patent number 6,821,985
- Issue date Nov 23, 2004
- Pfizer, Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole derivatives
- Patent number 6,756,385
- Issue date Jun 29, 2004
- Pfizer Inc.
- Mark A. Sanner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical combinations for the treatment of stroke and traumat...
- Patent number 6,667,317
- Issue date Dec 23, 2003
- Pfizer Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations for the treatment of parkinsonism containing selective...
- Patent number 6,258,827
- Issue date Jul 10, 2001
- Pfizer Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering AMPA receptor antagonists to treat dyskine...
- Patent number 6,136,812
- Issue date Oct 24, 2000
- Pfizer Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20240294546
- Publication date Sep 5, 2024
- Novartis AG
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20230023543
- Publication date Jan 26, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B
- Publication number 20230012073
- Publication date Jan 12, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20220274925
- Publication date Sep 1, 2022
- CADENT THERAPEUTICS, INC.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220153755
- Publication date May 19, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220047600
- Publication date Feb 17, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220016117
- Publication date Jan 20, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DENDRITIC CELL RECRUITMENT FROM BLOOD TO BRAIN IN NEURODEGENERATIVE...
- Publication number 20210181185
- Publication date Jun 17, 2021
- MINDIMMUNE THERAPEUTICS, INC.
- Brian Michael Campbell
- G01 - MEASURING TESTING
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20210107916
- Publication date Apr 15, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20200369610
- Publication date Nov 26, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20200087323
- Publication date Mar 19, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20190152912
- Publication date May 23, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B
- Publication number 20180325868
- Publication date Nov 15, 2018
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20180111902
- Publication date Apr 26, 2018
- Luc Therapeutics, Inc.
- David R. ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B
- Publication number 20170071906
- Publication date Mar 16, 2017
- LUC THERAPEUTICS, INC.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B
- Publication number 20150225342
- Publication date Aug 13, 2015
- Mnemosyne Pharmaceuticals, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazole derivatives
- Publication number 20060149066
- Publication date Jul 6, 2006
- Pfizer Inc.
- Mark A. Sanner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PDE 10 cell-based assay and sequences
- Publication number 20050026236
- Publication date Feb 3, 2005
- Pfizer Inc.
- Larry C. James
- G01 - MEASURING TESTING
Information Patent Application
NMDA NR2B antagonists for treatment
- Publication number 20040192763
- Publication date Sep 30, 2004
- Pfizer, Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Imidazole derivatives
- Publication number 20040192750
- Publication date Sep 30, 2004
- Pfizer Inc.
- Mark A. Sanner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20040162293
- Publication date Aug 19, 2004
- Pfizer Inc.
- Lorraine A. Lebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20040162294
- Publication date Aug 19, 2004
- Pfizer Inc.
- Lorraine A. Lebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Disruption of the phosphodiesterase 10 gene
- Publication number 20030121069
- Publication date Jun 26, 2003
- Pfizer Inc.
- Frank S. Menniti
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
PDE10 cell-based assay and sequences
- Publication number 20030096323
- Publication date May 22, 2003
- Pfizer Inc.
- Larry C. James
- G01 - MEASURING TESTING
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20030032579
- Publication date Feb 13, 2003
- Pfizer Inc.
- Lorraine A. Lebel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20030018047
- Publication date Jan 23, 2003
- Pfizer Inc.
- Lorraine A. Lebel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20030008806
- Publication date Jan 9, 2003
- Pfizer Inc.
- Lorraine A. Lebel
- G01 - MEASURING TESTING
Information Patent Application
Pharmaceutical combinations for the treatment of stroke and traumat...
- Publication number 20020123510
- Publication date Sep 5, 2002
- Pfizer Inc.
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Imidazole derivatives
- Publication number 20020119963
- Publication date Aug 29, 2002
- Mark A. Sanner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Prophylactic use of N-methyl-D-aspartate (NMDA) antagonists
- Publication number 20020072485
- Publication date Jun 13, 2002
- Bertrand L. Chenard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Frank S. Menniti

Person

Patents Grantslast 30 patents

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

Heteroaromatic NMDA receptor modulators and uses thereof

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...

NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

Thienopyrimidinone NMDA receptor modulators and uses thereof

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...

Heteroaromatic NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allos...

Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B

Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B

Imidazole derivatives

NMDA NR2B antagonists for treatment

NMDA NR2B antagonists for treatment

Pharmaceutical combinations for the treatment of stroke and traumat...

Imidazole derivatives

Pharmaceutical combinations for the treatment of stroke and traumat...

Combinations for the treatment of parkinsonism containing selective...

Methods of administering AMPA receptor antagonists to treat dyskine...

Patents Applicationslast 30 patents

NMDA RECEPTOR MODULATORS AND USES THEREOF

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

NMDA RECEPTOR MODULATORS AND USES THEREOF

THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF

THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF

DENDRITIC CELL RECRUITMENT FROM BLOOD TO BRAIN IN NEURODEGENERATIVE...

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

NMDA RECEPTOR MODULATORS AND USES THEREOF

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B

SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B

Imidazole derivatives

PDE 10 cell-based assay and sequences

NMDA NR2B antagonists for treatment

Imidazole derivatives

Therapeutic use of selective PDE10 inhibitors

Therapeutic use of selective PDE10 inhibitors

Disruption of the phosphodiesterase 10 gene

PDE10 cell-based assay and sequences

Therapeutic use of selective PDE10 inhibitors

Therapeutic use of selective PDE10 inhibitors

Therapeutic use of selective PDE10 inhibitors

Pharmaceutical combinations for the treatment of stroke and traumat...

Imidazole derivatives

Prophylactic use of N-methyl-D-aspartate (NMDA) antagonists